Using the National Endoscopy Database, researchers evaluated how the COVID-19 pandemic affected endoscopic activity and cancer detection in the U.K.
Five takeaways:
1. On average, 35,478 endoscopy procedures were performed on a weekly basis from Jan. 6 to March 15, a period researchers labeled “pre-COVID.”
2. From March 16-22, the number of endoscopy procedures performed dropped to 12 percent of pre-COVID levels.
3. Endoscopy procedures rebounded to 20 percent of normal by May 31, but at the lowest point in the time frame studied, volumes hit 5 percent of pre-COVID levels.
4. As a result of more selective patient vetting, the per-procedure cancer detection rate increased from 1.19 percent in the pre-COVID period to 6.61 percent from March 23 to May 31, the “COVID-impacted” period.
5. There was a 58 percent decrease in the number of cancers detected in the COVID-19 impacted period. The proportion of missing cancers ranged from 19 percent for pancreatobiliary to 72 percent for colorectal cancer.
More articles on surgery centers:
ASC considers in-house alternative to ‘overwhelmed’ hospital testing center — 3 insights
425 surgery centers that received PPP funds of more than $150K by state
4 COVID-19 testing insights for ASCs
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
